🟢 100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • Limited research evidence available for ingredients
B Label Compliance Grade

Product Label

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Label Data

1 Capsule(s) Serving Size
30 Servings
Other Combinations Product Type
0% Evidence Coverage

Supplement Facts — Evidence Check

Cyplexinol
200 mg
3-O-Acetyl-11-keto-beta-boswellic Acid
150 mg
ApresFlex
50 mg

Other Ingredients

Microcrystalline Cellulose Stearic Acid Magnesium Stearate Gelatin

Label Claims — Verification

All Other
Structure/Function

Target Groups

Adult (18 - 50 Years)

Product Information

📋 Directions for Use

Suggested Use: As a supplement take one (1) to two (2) Ostinol InstaJoint capsules two (2) times per day or as needed.

⚠️ Warnings & Precautions

Warning: Consult a healthcare provider before using if pregnant, nursing or on medication.

Do not use if inner seal is missing or broken.

Keep out of the reach of children.

🧪 Formulation Notes

Ostinol InstaJoint contains Cyplexinol Std, a natural growth-factor BMP-complex.

BMP complexes are functionally involved in the formation of bone and cartilage tissue, however limited studies for oral administration are available but ongoing.

Additionally, Ostinol InstaJoint contains boswellic acid (AKBA), enriched to 65%. ApresFlex, a licensed ingredient from PLT Health Solution, is added to support joints in as few as 5 days according to their clinical results.

AprèsFlex Powered by Cyplexinol Nature's BMP - Complex

Improved with ApresFlex

5-day joint support

Additional Information

Store in a cool, dry place.

Product Details

UPC / SKU 8 57208 00648 4
DSLD Entry Date 2025-03-25
Product Type Other Combinations
Form Capsule
DSLD ID 323398
Data Updated 2026-04-11

Research Evidence

We're building the evidence profile for this product's ingredients.

Our team is working to connect every product on the American market with peer-reviewed research. Check back soon for evidence-backed analysis.